
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML>
<HEAD>
<META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=ISO-8859-1">
<META NAME="Copyright" CONTENT="© 2004-2017 PharmaInformatic, Emden Germany,  All rights reserved.">
<META NAME="Description" CONTENT="PharmaInformatic is a German biotech company, which provides ADME/Tox Knowledge Bases and predictive tools (Expert Systems) to improve drug discovery and development.
The expert system IMPACT-F predicts oral bioavailability of novel drugs in humans much more reliable than animal trials.
">
<META NAME="Keywords" CONTENT="IMPACT-F, bioavailability, drugs, clinical trials, preclinical animal trials, prediction, expert system, drug candidates, Pharmacokinetics, drug design, drug development, ADME, FAQ">
<META NAME="Generator" CONTENT="NetObjects Fusion 7.5 für Windows">
<META NAME="Language" CONTENT="english">
<TITLE>IMPACT-F</TITLE>
<SCRIPT>
<!--
function F_loadRollover(){} function F_roll(){}
//-->
</SCRIPT>
<SCRIPT LANGUAGE="JavaScript1.2" SRC="../assets/rollover.js"></SCRIPT>
<LINK REL=STYLESHEET TYPE="text/css" HREF="../html/style.css">
<LINK REL=STYLESHEET TYPE="text/css" HREF="../html/site.css">
<STYLE>
</STYLE><NOLAYER>
<STYLE ID="NOF_STYLE_SHEET">
<!--
DIV#LayoutLYR { position:absolute; top:0; left:0; z-index: 1; visibility:inherit; }
DIV#Navigationsleiste2LYR { position:absolute; visibility:inherit; top:0; left:187; width:800; height:35; z-index:1 }
DIV#Navigationsleiste21LYR { position:absolute; visibility:hidden; top:0; left:0; z-index:1; }
DIV#Navigationsleiste22LYR { position:absolute; visibility:hidden; top:0; left:0; z-index:1; }
DIV#Navigationsleiste23LYR { position:absolute; visibility:hidden; top:0; left:0; z-index:1; }
DIV#Navigationsleiste24LYR { position:absolute; visibility:hidden; top:0; left:0; z-index:1; }
DIV#Navigationsleiste25LYR { position:absolute; visibility:hidden; top:0; left:0; z-index:1; }
DIV#Bild2LYR { position:absolute; visibility:inherit; top:78; left:0; width:187; height:58; z-index:2 }
DIV#Bild3LYR { position:absolute; visibility:inherit; top:35; left:187; width:800; height:101; z-index:3 }
DIV#Bild1LYR { position:absolute; visibility:inherit; top:0; left:0; width:187; height:78; z-index:4 }
DIV#Tabelle2LYR { position:absolute; visibility:inherit; top:3841; left:0; width:985; height:19; z-index:5 }
DIV#Bild5LYR { position:absolute; visibility:inherit; top:136; left:0; width:987; height:1; z-index:6 }
DIV#Text59LYR { position:absolute; visibility:inherit; top:137; left:0; width:184; height:804; z-index:7 }
DIV#Text62LYR { position:absolute; visibility:inherit; top:1126; left:0; width:184; height:971; z-index:8 }
DIV#Text64LYR { position:absolute; visibility:inherit; top:2379; left:0; width:184; height:354; z-index:9 }
DIV#Text61LYR { position:absolute; visibility:inherit; top:137; left:184; width:656; height:554; z-index:10 }
DIV#Text16LYR { position:absolute; visibility:inherit; top:1146; left:858; width:130; height:860; z-index:11 }
DIV#Bild21LYR { position:absolute; visibility:inherit; top:688; left:370; width:292; height:137; z-index:12 }
DIV#Text8LYR { position:absolute; visibility:inherit; top:871; left:184; width:656; height:152; z-index:13 }
DIV#Tabelle3LYR { position:absolute; visibility:inherit; top:1097; left:224; width:615; height:2534; z-index:14 }
DIV#Text63LYR { position:absolute; visibility:inherit; top:137; left:858; width:130; height:886; z-index:15 }
-->
</STYLE>

</NOLAYER>
</HEAD>
<BODY NOF="(MB=(ProduIMPACT, 137, 19, 184, 0), L=(IMPACTFLayout, 804, 3704))">
    <DIV ID="LayoutLYR"><LAYER ID="LayoutLYR" TOP=0 LEFT=0 VISIBILITY=INHERIT WIDTH=988 HEIGHT=3860 Z-INDEX=1><DIV ID="Text61LYR" CLASS="TextObject"><LAYER ID="Text61LYR" VISIBILITY=INHERIT TOP=137 LEFT=184 WIDTH=656 HEIGHT=554 Z-INDEX=1>
    <UL>
        <UL>
            <UL>
                <UL>
                    <UL>
                        <UL>
                            <UL>
                                <P STYLE="text-align: justify;"><B><SPAN STYLE="font-size: medium;">&nbsp;&nbsp; <BR>&nbsp;IMPACT-F</SPAN></B></P>
                            </UL>
                        </UL>
                    </UL>
                </UL>
            </UL>
            <P STYLE="text-align: left;"><B><SPAN STYLE="font-size: medium;">&nbsp;&nbsp; &nbsp; Predicting human oral bioavailability of future drug candidates</SPAN></B></P>
        </UL>
        <P STYLE="text-align: justify;"><SPAN STYLE="font-size: 12pt;">The evaluation of oral bioavailability is based on reliable computational models, which have been derived from the largest knowledge base on bioavailability worldwide (PACT-F). The early prediction of human oral bioavailability has several advantages:</SPAN></P>
        <UL>
            <LI STYLE="text-align: justify;"><SPAN STYLE="font-size: 12pt;">selection of bioavailable drug candidates ==&gt; reduces clinical failures<BR></SPAN>&nbsp;</LI>
            <LI STYLE="text-align: justify;"><SPAN STYLE="font-size: 12pt;">much more reliable than animal trials, results almost immediately available<BR></SPAN>&nbsp;</LI>
            <LI STYLE="text-align: justify;"><SPAN STYLE="font-size: 12pt;">confidential and reliable (no data or information leaves your company)<BR></SPAN>&nbsp;</LI>
            <LI STYLE="text-align: justify;"><SPAN STYLE="font-size: 12pt;">increases the prospects of novel drugs, because the optimum oral dose for first-in-human clinical trials can be determined much more accurately.<BR></SPAN>&nbsp;</LI>
            <LI STYLE="text-align: justify;"><SPAN STYLE="font-size: 12pt;">unrivalled method to evaluate efficiency of drugs <I>before</I> clinical trials in humans</SPAN></LI>
        </UL>
        <P STYLE="text-align: justify;"><SPAN STYLE="font-size: 12pt;">IMPACT-F is used by <A HREF="../html/partnerships.html">pharmaceutical companies</A> in different therapeutic areas such as diabetes, inflammation, antivirals, autoimmune diseases and cancer for selection and prioritisation of drug candidates, to optimise prodrugs and to evaluate oral bioavailability before clinical trials in humans, see recent <A HREF="../html/partnerships.html">collaborations</A>.</SPAN></P>
        <P STYLE="text-align: justify;"><SPAN STYLE="font-size: 12pt;">To use our prediction service or to obtain more information, please give us a call (+49 4921-993360) or send an <A HREF="mailto:prediction-service@pharmaInformatic.com">email</A> by clicking the button:</SPAN></P>
        <P STYLE="text-align: justify;"><SPAN STYLE="font-size: 12pt;"></SPAN>&nbsp;</P>
    </UL>
    </LAYER></DIV><DIV ID="Text16LYR" CLASS="TextObject" STYLE="background-color: rgb(255,255,255); background-image: url('../assets/images/PixelHellblau.jpg');"><LAYER ID="Text16LYR" VISIBILITY=INHERIT TOP=1146 LEFT=858 WIDTH=130 HEIGHT=860 Z-INDEX=2  bgcolor="#FFFFFF" background="../assets/images/PixelHellblau.jpg">
    <P STYLE="text-align: center; border: 1pt solid rgb(137,211,238); margin: 2pt;"><A HREF="../html/impact-f.html"><IMG ID="Bild12" HEIGHT=79 WIDTH=119 SRC="../assets/images/IMPACT-F_343-6_120.png" VSPACE=0 HSPACE=0 ALIGN="TOP" BORDER=0 ALT=""></A></P>
    <P STYLE="text-align: center; border: 1pt solid rgb(137,211,238); margin: 2pt;"><SPAN STYLE="font-size: x-small;"></SPAN><B></B>&nbsp;<BR><B>IMPACT-F:<BR>Download<BR>product flyer<BR>(pdf)</A><BR></B>&nbsp;</P>
    <P STYLE="text-align: center; border: 1pt solid rgb(137,211,238); margin: 2pt;"><BR>Prediction of oral bioavailability reduces failures in clinical trials.<BR>&nbsp;</P>
    <P STYLE="text-align: center; margin: 2pt; border-left-style: none; border-top-style: none; border-right-style: none; border-bottom-style: none;"><BR>&nbsp;&nbsp; <B>Related Links:</B><BR><A HREF="../html/novel_descriptors.html">Cheminformatics</A><BR><A HREF="../html/impact-f.html">ADME-Software</A><BR><A HREF="../html/what_influences_f__.html">Pharmacokinetics</A><BR><A HREF="../html/science___technology.html">Computational chemistry</A><BR><A HREF="../html/scientific_network.html">Molecular<BR>modeling</A><BR><BR><B>IND:</B><BR>Investigational new drug<BR><BR><B>NCEs:</B><BR>New chemical entities<BR><BR><B>DMPK:</B><BR>Drug <BR>metabolism <BR>and pharmacokinetics<BR><BR><B>NDA:</B><BR>New drug<BR>application<BR>&nbsp;</P>
    </LAYER></DIV><DIV ID="Bild21LYR"><LAYER ID="Bild21LYR" VISIBILITY=INHERIT TOP=688 LEFT=370 WIDTH=292 HEIGHT=137 Z-INDEX=3><IMG ID="Bild21" HEIGHT=137 WIDTH=292 SRC="../assets/images/prediction-service_large.jpg" BORDER=0 ALT="" USEMAP="#map0"><MAP NAME="map0"><AREA SHAPE=RECT ALT="" COORDS="0,0,292,137" HREF="mailto:prediction-service@pharmaInformatic.com"></MAP></LAYER></DIV><DIV ID="Text8LYR" CLASS="TextObject"><LAYER ID="Text8LYR" VISIBILITY=INHERIT TOP=871 LEFT=184 WIDTH=656 HEIGHT=152 Z-INDEX=4>
    <UL>
        <P STYLE="text-align: justify;"><SPAN STYLE="font-size: 12pt;">Oral bioavailability is a key property in drug design and development. Poor bioavailability of a drug results in low efficacy and higher inter-subject variability and therefore can lead to unpredictable response to a drug. </SPAN></P>
        <P STYLE="text-align: justify;"><SPAN STYLE="font-size: 12pt;">To summarise the novel expert system IMPACT-F is easy to use, it requires no chemical synthesis or animal experiments, it is much more reliable than animal trials and results are almost immediately available. It is an important method in future drug discovery and development which improves efficiency and safety of human clinical trials.</SPAN></P>
    </UL>
    </LAYER></DIV><DIV ID="Tabelle3LYR"><LAYER ID="Tabelle3LYR" VISIBILITY=INHERIT TOP=1097 LEFT=224 WIDTH=615 HEIGHT=2534 Z-INDEX=5>
    <TABLE ID="Tabelle3" BORDER=0 CELLSPACING=3 CELLPADDING=1 WIDTH="100%">
        <TR>
            <TD WIDTH=607 HEIGHT=31>
                <P STYLE="text-align: left;"><A NAME="FAQ"></A>&nbsp;</P>
                <P STYLE="text-align: left;">&nbsp;</P>
                <P STYLE="text-align: left;"><B><SPAN STYLE="font-size: medium;">&nbsp;&nbsp;  Frequently Asked Questions (FAQ):</SPAN></B></P>
                <P STYLE="text-align: left;"><B><SPAN STYLE="font-size: medium;"></SPAN></B>&nbsp;</P>
            </TD>
        </TR>
        <TR>
            <TD WIDTH=607 HEIGHT=50>
                <P>&nbsp;&nbsp; &nbsp; <A HREF="#NCE">Can IMPACT-F predict human oral bioavailability of entirely new molecules?</A></P>
            </TD>
        </TR>
        <TR>
            <TD WIDTH=607 HEIGHT=50>
                <P>&nbsp;&nbsp; &nbsp; <A HREF="#therapeutic areas">Is IMPACT-F restricted to a specific therapeutic area, such as antivirals or cancer?</A></P>
            </TD>
        </TR>
        <TR>
            <TD WIDTH=607 HEIGHT=50>
                <P>&nbsp;&nbsp; &nbsp; <A HREF="#requirements">What is required to predict oral bioavailability with IMPACT-F?</A></P>
            </TD>
        </TR>
        <TR>
            <TD WIDTH=607 HEIGHT=50>
                <P>&nbsp;&nbsp; &nbsp; <A HREF="#phasedrugdevelopment">At which stage of drug discovery and development should IMPACT-F be applied?</A></P>
            </TD>
        </TR>
        <TR>
            <TD HEIGHT=19>
                <P>&nbsp;</P>
            </TD>
        </TR>
        <TR>
            <TD WIDTH=607>
                <P STYLE="text-align: justify;"><A NAME="NCE"></A>&nbsp;</P>
                <P STYLE="text-align: justify;"><B>Question: </B></P>
                <P STYLE="text-align: justify;"><I>My company has discovered a new chemical entity (NCE) with a novel and unique mechanism of action. Up to now, no similar molecules have been investigated in human clinical trials. Can IMPACT-F predict human oral bioavailability of entirely new molecules?</I></P>
                <P STYLE="text-align: justify;"><B>Answer:&nbsp; </B>Yes. In cooperation with a pharmaceutical company, we have investigated this question. We have found that constantly good prediction results are obtained, regardless of whether highly similar compounds are present in PACT-F, the underlying knowledge base of IMPACT-F. </P>
                <P STYLE="text-align: justify;">In fact, more than 82% of the investigated drug-candidates showed a maximal Tanimoto similarity below 0.67. This shows that highly similar drugs are not needed to reliably estimate the oral bioavailability of entirely novel drug structures. Please contact us if you are interested in the <A HREF="mailto:prediction-service@pharmaInformatic.com">detailed report</A>.</P>
                <P STYLE="text-align: justify;">On the other hand, we found that small changes in molecular structure can dramatically influence the oral bioavailability of a drug candidate.</P>
                <P STYLE="text-align: justify;">IMPACT-F uses and combines all available information in PACT-F from previous known bioavailability to create a reliable estimate of oral bioavailability in humans.</P>
                <P STYLE="text-align: justify;">&nbsp;</P>
            </TD>
        </TR>
        <TR>
            <TD WIDTH=607>
                <P STYLE="text-align: justify;"><A NAME="therapeutic areas"></A>&nbsp;</P>
                <P STYLE="text-align: justify;"><B>Question: </B></P>
                <P STYLE="text-align: justify;"><I>Is IMPACT-F restricted to a specific therapeutic area, such as antibiotics, cardiovascular drugs, or cancer therapeutics? </I></P>
                <P STYLE="text-align: justify;"><B>Answer:&nbsp; </B>No, there is no restriction on a specific therapeutic area. IMPACT-F can predict the oral bioavailability of small-molecule drug-candidates ranging across all therapeutic areas.</P>
                <P STYLE="text-align: justify;">We have evaluated IMPACT-F with drugs and drug-candidates from all therapeutic areas, such as cardiovascular, cancer, gastrointestinal, pain, antivirals, antibacterials, inflammation, anticoagulants, antiepileptic drugs, Alzheimers and Parkinsons disease, renal diseases, Multiple Sclerosis, respiratory diseases, antidiabetic agents, COPD, asthma, rheumatoid arthritis, obesity, metabolic disorders, central nervous system disorders. Reliable prediction results were achieved in all cases, so there is no restriction to a specific therapeutic area.</P>
                <P STYLE="text-align: justify;">IMPACT-F has been used by pharmaceutical companies in different therapeutic areas (cancer, diabetes, inflammation, autoimmune diseases, antivirals) for selection and prioritisation of drug candidates, to optimise prodrugs and to evaluate oral bioavailability before advanced clinical trials in humans, <SPAN STYLE="font-size: 12pt;">see <A HREF="../html/partnerships.html">recent collaborations</A>.</SPAN></P>
                <P>&nbsp;</P>
            </TD>
        </TR>
        <TR>
            <TD WIDTH=607>
                <P STYLE="text-align: justify;"><A NAME="requirements"></A>&nbsp;</P>
                <P STYLE="text-align: justify;"><B>Question: </B></P>
                <P STYLE="text-align: justify;"><I>What is required to predict oral bioavailability with IMPACT-F (in vivo PK in rats, measured logP)?</I> </P>
                <P STYLE="text-align: justify;"><B>Answer:&nbsp; </B>The structure of the drug-candidate and time to do the calculations, thats all.</P>
                <P STYLE="text-align: justify;">Eight years ago, our aim was to create an expert system which was not dependent on additional experimental input parameters. They take time to generate, different conditions in measurement cannot always be unified, and chemical synthesis is expensive and takes time as well. </P>
                <P STYLE="text-align: justify;">The chemical structure of an investigational compound is available at a very early time in drug discovery projects, even before chemical synthesis and preclinical experiments can take place. If the decision to develop a compound further can be made at the earliest possibility, then more money and time can be saved and resources can be concentrated on the most prospective ones.</P>
                <P STYLE="text-align: justify;">In drug discovery it is important to identify useful drug candidates at the earliest opportunity. A large amount of time and money is spent on candidates which will never come to market. </P>
                <P STYLE="text-align: justify;">Low oral bioavailability in clinical trials is one of the main reasons why clinical trials fail.</P>
                <P STYLE="text-align: justify;">&nbsp;</P>
            </TD>
        </TR>
        <TR>
            <TD WIDTH=607>
                <P STYLE="text-align: justify;"><A NAME="phasedrugdevelopment"></A>&nbsp;</P>
                <P STYLE="text-align: justify;"><B>Question: </B></P>
                <P STYLE="text-align: justify;"><I>At which stage of drug discovery and development should IMPACT-F be applied?</I></P>
                <P STYLE="text-align: justify;"><B>Answer: </B> The earlier the better! Many drug-candidates fail in clinical trials due to low oral bioavailability in humans. As a result billions of Euros are wasted every year on drug-candidates which never reach the market. IMPACT-F identifies these failures and substantially reduces drug development costs and time involved.</P>
                <P STYLE="text-align: justify;">IMPACT-F has now been used by several <A HREF="../html/partnerships.html">pharmaceutical companies</A>, even though the technology was launched only a few months ago. </P>
                <P STYLE="text-align: justify;">Up to now, the expert system was applied in different phases of drug discovery and development. On the one hand within the preclinical discovery phase to <A HREF="../html/partnerships.html">optimise and select drug candidates</A> with high oral bioavailability. On the other hand IMPACT-F has estimated the oral bioavailability of drug-candidates which are scheduled for <A HREF="../html/partnerships.html">clinical trials</A> in humans.</P>
                <P STYLE="text-align: justify;"><BR><BR>Read current press release: <A HREF="../html/lead_optimization.html#PM">Pharma uses IMPACT-F to predict drug efficacy</A><BR>&nbsp;</P>
                <P STYLE="text-align: justify;">Further explanations and abbreviations:<BR><BR><A HREF="../html/lead_optimization.html">Lead optimization (LO):</A><BR>Drug discovery often starts from initial hits with pharmacological activity. Structural modifications of compound structure yield to optimised leads. They can proceed to drug candidates, which are further investigated in clinical trials in humans.<BR><BR><A HREF="../html/lead_prioritisation.html">Quantitative structure activity relationship (QSAR):</A><BR>Chemical structures are set in relation to their biological activity.<BR><BR><A HREF="../html/adme___tox_predictions.html">Absorption &amp; distribution &amp; metabolism &amp; excretion (ADME):</A><BR>Oral bioavailability combines both absorption and metabolism <BR><BR><A HREF="../html/impact-f.html">Quantitative structure property relationship (QSPR):</A><BR>Oral bioavailability is a main property of leads and drug candidates.<BR><BR>&nbsp;</P>
            </TD>
        </TR>
    </TABLE>
    </LAYER></DIV><DIV ID="Text63LYR" CLASS="TextObject" STYLE="background-color: rgb(255,255,255); background-image: url('../assets/images/PixelHellblau.jpg');"><LAYER ID="Text63LYR" VISIBILITY=INHERIT TOP=137 LEFT=858 WIDTH=130 HEIGHT=886 Z-INDEX=6  bgcolor="#FFFFFF" background="../assets/images/PixelHellblau.jpg">
    <P STYLE="text-align: center; border: 1pt solid rgb(137,211,238); margin: 2pt;"><A HREF="../html/impact-f.html"><IMG ID="Bild23" HEIGHT=79 WIDTH=119 SRC="../assets/images/IMPACT-F_343-6_120.png" VSPACE=0 HSPACE=0 ALIGN="TOP" BORDER=0 ALT=""></A></P>
    <P STYLE="text-align: center; border: 1pt solid rgb(137,211,238); margin: 2pt;"><SPAN STYLE="font-size: x-small;"></SPAN><B></B>&nbsp;<BR><B>IMPACT-F:<BR><A HREF="../IMPACT-F_description.pdf">Download<BR>product flyer<BR>(pdf)</A><BR></B>&nbsp;</P>
    <P STYLE="text-align: center; border: 1pt solid rgb(137,211,238); margin: 2pt;"><BR>Prediction of oral bioavailability reduces clinical failures and increases safety and prospects of clinical trials.<BR>&nbsp;</P>
    <P STYLE="text-align: center; border: 1pt solid rgb(137,211,238); margin: 2pt;"><BR><B>&nbsp;<A HREF="#FAQ">Frequently Asked Questions (FAQ)</A><BR></B>&nbsp;</P>
    <P STYLE="text-align: center; border: 1pt solid rgb(137,211,238); margin: 2pt;"><B><BR>New collaboration:<BR><BR>CRACK IT <BR><A HREF="https://crackit.org.uk/challenge-27-doce">DoCE</A> <BR>Challenge <BR></B><BR>Sponsored by Unilever <BR>&amp; Shell <BR>this challenge aims to develop methods and tools that will better quantify and control the exposure of chemicals for predicting in vivo toxicity.<BR>&nbsp;</P>
    </LAYER></DIV><DIV ID="Navigationsleiste2LYR"><LAYER ID="Navigationsleiste2LYR" VISIBILITY=INHERIT TOP=0 LEFT=187 WIDTH=800 HEIGHT=35 Z-INDEX=7>
    <TABLE ID="Navigationsleiste2" BORDER=0 CELLSPACING=0 CELLPADDING=0 NOF=NB_FNHPNY021 WIDTH=800>
        <TR VALIGN=TOP ALIGN=LEFT>
            <TD WIDTH=160><A HREF="../html/about_pharmainformatic.html" onMouseOver="F_roll('Navigationsschaltflaeche1',1)" onMouseOut="F_roll('Navigationsschaltflaeche1',0)"><ILAYER ID="Navigationsschaltflaeche1"></ILAYER><IMG ID="Navigationsschaltflaeche1" NAME="Navigationsschaltflaeche1" HEIGHT=35 WIDTH=160 SRC="../assets/images/autogen/About_PharmaInformatic_Nbutton_pri_1.jpg" onLoad="F_loadRollover(this,'About_PharmaInformatic_NRbutton_pri_3.jpg',new Array(35, 'Navigationsleiste21',true))" BORDER=0 ALT="About PharmaInformatic" TITLE="About PharmaInformatic"></A></TD>
            <TD WIDTH=160><A HREF="../html/products.html" onMouseOver="F_roll('Navigationsschaltflaeche2',1)" onMouseOut="F_roll('Navigationsschaltflaeche2',0)"><ILAYER ID="Navigationsschaltflaeche2"></ILAYER><IMG ID="Navigationsschaltflaeche2" NAME="Navigationsschaltflaeche2" HEIGHT=35 WIDTH=160 SRC="../assets/images/autogen/Products_Hbutton_pri_2.jpg" onLoad="F_loadRollover(this,'Products_HRbutton_pri_4.jpg',new Array(35, 'Navigationsleiste22',true))" BORDER=0 ALT="Products" TITLE="Products"></A></TD>
            <TD WIDTH=160><A HREF="../html/databases.html" onMouseOver="F_roll('Navigationsschaltflaeche3',1)" onMouseOut="F_roll('Navigationsschaltflaeche3',0)"><ILAYER ID="Navigationsschaltflaeche3"></ILAYER><IMG ID="Navigationsschaltflaeche3" NAME="Navigationsschaltflaeche3" HEIGHT=35 WIDTH=160 SRC="../assets/images/autogen/Databases_Nbutton_pri_1.jpg" onLoad="F_loadRollover(this,'Databases_NRbutton_pri_3.jpg',new Array(35, 'Navigationsleiste23',true))" BORDER=0 ALT="Databases" TITLE="Databases"></A></TD>
            <TD WIDTH=160><A HREF="../html/lead_optimization.html" onMouseOver="F_roll('Navigationsschaltflaeche4',1)" onMouseOut="F_roll('Navigationsschaltflaeche4',0)"><ILAYER ID="Navigationsschaltflaeche4"></ILAYER><IMG ID="Navigationsschaltflaeche4" NAME="Navigationsschaltflaeche4" HEIGHT=35 WIDTH=160 SRC="../assets/images/autogen/Lead_optimization_Nbutton_pri_1.jpg" onLoad="F_loadRollover(this,'Lead_optimization_NRbutton_pri_3.jpg',new Array(35, 'Navigationsleiste24',true))" BORDER=0 ALT="Lead optimization" TITLE="Lead optimization"></A></TD>
            <TD WIDTH=160 HEIGHT=35><A HREF="../html/service___support.html" onMouseOver="F_roll('Navigationsschaltflaeche5',1)" onMouseOut="F_roll('Navigationsschaltflaeche5',0)"><ILAYER ID="Navigationsschaltflaeche5"></ILAYER><IMG ID="Navigationsschaltflaeche5" NAME="Navigationsschaltflaeche5" HEIGHT=35 WIDTH=160 SRC="../assets/images/autogen/Service___Support_Nbutton_pri_1.jpg" onLoad="F_loadRollover(this,'Service___Support_NRbutton_pri_3.jpg',new Array(35, 'Navigationsleiste25',true))" BORDER=0 ALT="Service & Support" TITLE="Service & Support"></A></TD>
        </TR>
    </TABLE>
    </LAYER></DIV><DIV ID="Bild2LYR"><LAYER ID="Bild2LYR" VISIBILITY=INHERIT TOP=78 LEFT=0 WIDTH=187 HEIGHT=58 Z-INDEX=8><IMG ID="Bild2" HEIGHT=58 WIDTH=187 SRC="../assets/images/molekuelbanner_neu_links.jpg" BORDER=0 ALT=""></LAYER></DIV><DIV ID="Bild3LYR"><LAYER ID="Bild3LYR" VISIBILITY=INHERIT TOP=35 LEFT=187 WIDTH=800 HEIGHT=101 Z-INDEX=9><IMG ID="Bild3" HEIGHT=101 WIDTH=800 SRC="../assets/images/molekuelbanner_neu_rechts.jpg" BORDER=0 ALT=""></LAYER></DIV><DIV ID="Bild1LYR"><LAYER ID="Bild1LYR" VISIBILITY=INHERIT TOP=0 LEFT=0 WIDTH=187 HEIGHT=78 Z-INDEX=10><A HREF="../index.html"><IMG ID="Bild1" HEIGHT=78 WIDTH=187 SRC="../assets/images/logo_mit_blau.jpg" BORDER=0 ALT=""></A></LAYER></DIV><DIV ID="Tabelle2LYR" STYLE="background-color: rgb(182,182,255);"><LAYER ID="Tabelle2LYR" VISIBILITY=INHERIT TOP=3841 LEFT=0 WIDTH=985 HEIGHT=19 Z-INDEX=11  bgcolor="#B6B6FF">
    <TABLE ID="Tabelle2" BORDER=1 BGCOLOR="#B6B6FF" CELLSPACING=0 CELLPADDING=1 WIDTH="100%">
        <TR>
            <TD WIDTH=979 STYLE="background-color: rgb(137,211,238);" HEIGHT=13>
                <P STYLE="text-align: right;"><SPAN STYLE="font-size: xx-small;">&#169; <B>Copyright 2004-2021 PharmaInformatic Boomgaarden. All rights reserved. &nbsp; &nbsp; &nbsp; &nbsp;  <A HREF="../html/site_map.html">Site map</A> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;  <A HREF="../html/contact_us.html">Contact</A> &nbsp; &nbsp; &nbsp; &nbsp;  <A HREF="../html/terms_of_use.html">Terms of Use</A> &nbsp; &nbsp; &nbsp; &nbsp;  <A HREF="../html/imprint___copyright.html">Imprint</A> &nbsp; &nbsp; &nbsp; &nbsp;  </B></SPAN></P>
            </TD>
        </TR>
    </TABLE>
    </LAYER></DIV><DIV ID="Bild5LYR"><LAYER ID="Bild5LYR" VISIBILITY=INHERIT TOP=136 LEFT=0 WIDTH=987 HEIGHT=1 Z-INDEX=12><IMG ID="Bild5" HEIGHT=1 WIDTH=987 SRC="../assets/images/balken_schwarz.jpg" BORDER=0 ALT=""></LAYER></DIV><DIV ID="Text59LYR" CLASS="TextObject" STYLE="background-color: rgb(255,255,255); background-image: url('../assets/images/PixelHellblau.jpg');"><LAYER ID="Text59LYR" VISIBILITY=INHERIT TOP=137 LEFT=0 WIDTH=184 HEIGHT=804 Z-INDEX=13  bgcolor="#FFFFFF" background="../assets/images/PixelHellblau.jpg">
    <P STYLE="text-align: center; border: 1pt solid rgb(137,211,238); margin: 2pt;"><BR>
        <TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0 NOF=TE>
            <TR>
                <TD ALIGN="CENTER"><IMG ID="Bild11" HEIGHT=113 WIDTH=170 SRC="../assets/images/IMPACT-F_343-6_170.png" BORDER=0 ALT="" USEMAP="#map1"><MAP NAME="map1"><AREA SHAPE=RECT ALT="" COORDS="0,0,170,113" HREF="../html/impact-f.html"></MAP></TD>
            </TR>
        </TABLE>
        <BR></P>
    <P STYLE="text-align: center; border: 1pt solid rgb(137,211,238); margin: 2pt;"><BR>
        <TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0 NOF=TE>
            <TR>
                <TD ALIGN="CENTER">
                    <TABLE ID="Navigationsleiste5" BORDER=0 BGCOLOR="#FFFFFF" CELLSPACING=4 CELLPADDING=0 NOF=NB_UNVSNY020NOF=NB_UNVSNY020NOF=NB_UNVSNY020 WIDTH=168>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../index.html" onMouseOver="F_roll('Navigationsschaltflaeche6',1)" onMouseOut="F_roll('Navigationsschaltflaeche6',0)"><IMG ID="Navigationsschaltflaeche6" NAME="Navigationsschaltflaeche6" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/Home_Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'Home_NRbutton_sec_3.jpg',0)" BORDER=0 ALT="Home" TITLE="Home"></A></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><IMG ID="Navigationsschaltflaeche7" NAME="Navigationsschaltflaeche7" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/IMPACT-F_Brochure__pdf__Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'IMPACT-F_Brochure__pdf__NRbutton_sec_3.jpg',0)" BORDER=0 ALT="IMPACT-F Brochure (pdf)" TITLE="IMPACT-F Brochure (pdf)"></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="mailto:prediction-service@pharmaInformatic.com" onMouseOver="F_roll('Navigationsschaltflaeche8',1)" onMouseOut="F_roll('Navigationsschaltflaeche8',0)"><IMG ID="Navigationsschaltflaeche8" NAME="Navigationsschaltflaeche8" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/Prediction_Service__email__Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'Prediction_Service__email__NRbutton_sec_3.jpg',0)" BORDER=0 ALT="Prediction Service (email)" TITLE="Prediction Service (email)"></A></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/lead_optimization.html" onMouseOver="F_roll('Navigationsschaltflaeche9',1)" onMouseOut="F_roll('Navigationsschaltflaeche9',0)"><IMG ID="Navigationsschaltflaeche9" NAME="Navigationsschaltflaeche9" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/Validation_of_IMPACT-F_Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'Validation_of_IMPACT-F_NRbutton_sec_3.jpg',0)" BORDER=0 ALT="Validation of IMPACT-F" TITLE="Validation of IMPACT-F"></A></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/lead_prioritisation.html" onMouseOver="F_roll('Navigationsschaltflaeche10',1)" onMouseOut="F_roll('Navigationsschaltflaeche10',0)"><IMG ID="Navigationsschaltflaeche10" NAME="Navigationsschaltflaeche10" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/Lead_prioritisation_Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'Lead_prioritisation_NRbutton_sec_3.jpg',0)" BORDER=0 ALT="Lead prioritisation" TITLE="Lead prioritisation"></A></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/pact-f.html" onMouseOver="F_roll('Navigationsschaltflaeche11',1)" onMouseOut="F_roll('Navigationsschaltflaeche11',0)"><IMG ID="Navigationsschaltflaeche11" NAME="Navigationsschaltflaeche11" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/PACT-F__knowledge_base__Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'PACT-F__knowledge_base__NRbutton_sec_3.jpg',0)" BORDER=0 ALT="PACT-F (knowledge base)" TITLE="PACT-F (knowledge base)"></A></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/plasma_protein_binding.html" onMouseOver="F_roll('Navigationsschaltflaeche12',1)" onMouseOut="F_roll('Navigationsschaltflaeche12',0)"><IMG ID="Navigationsschaltflaeche12" NAME="Navigationsschaltflaeche12" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/Plasma_Protein_Binding_Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'Plasma_Protein_Binding_NRbutton_sec_3.jpg',0)" BORDER=0 ALT="Plasma Protein Binding" TITLE="Plasma Protein Binding"></A></TD>
                        </TR>
                    </TABLE>
                </TD>
            </TR>
        </TABLE>
        <BR></P>
    <P STYLE="text-align: center; border: 1pt solid rgb(137,211,238); margin: 2pt;"><BR>
        <TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0 NOF=TE>
            <TR>
                <TD ALIGN="CENTER">
                    <TABLE ID="Navigationsleiste8" BORDER=0 BGCOLOR="#FFFFFF" CELLSPACING=0 CELLPADDING=0 NOF=NB_UNVSNY020NOF=NB_UNVSNY020NOF=NB_UNVSNY020 WIDTH=160>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/blockbuster_drugs.html" onMouseOver="F_roll('Navigationsschaltflaeche18',1)" onMouseOut="F_roll('Navigationsschaltflaeche18',0)"><IMG ID="Navigationsschaltflaeche18" NAME="Navigationsschaltflaeche18" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/Oral_Bioavailability_of_Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'Oral_Bioavailability_of_NRbutton_sec_3.jpg',0)" BORDER=0 ALT="Oral Bioavailability of" TITLE="Oral Bioavailability of"></A></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/blockbuster_drugs.html" onMouseOver="F_roll('Navigationsschaltflaeche19',1)" onMouseOut="F_roll('Navigationsschaltflaeche19',0)"><IMG ID="Navigationsschaltflaeche19" NAME="Navigationsschaltflaeche19" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/Blockbuster_Drugs_Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'Blockbuster_Drugs_NRbutton_sec_3.jpg',0)" BORDER=0 ALT="Blockbuster Drugs" TITLE="Blockbuster Drugs"></A></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/blockbuster_drugs.html" onMouseOver="F_roll('Navigationsschaltflaeche20',1)" onMouseOut="F_roll('Navigationsschaltflaeche20',0)"><IMG ID="Navigationsschaltflaeche20" NAME="Navigationsschaltflaeche20" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/in_Humans_and_Animals_Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'in_Humans_and_Animals_NRbutton_sec_3.jpg',0)" BORDER=0 ALT="in Humans and Animals" TITLE="in Humans and Animals"></A></TD>
                        </TR>
                    </TABLE>
                </TD>
            </TR>
        </TABLE>
        <BR></P>
    <P STYLE="text-align: center; border: 1pt solid rgb(137,211,238); margin: 2pt;"><BR>
        <TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0 NOF=TE>
            <TR>
                <TD ALIGN="CENTER">
                    <TABLE ID="Navigationsleiste3" BORDER=0 BGCOLOR="#FFFFFF" CELLSPACING=0 CELLPADDING=0 NOF=NB_UNVSNY020NOF=NB_UNVSNY020NOF=NB_UNVSNY020 WIDTH=160>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/prediction_of_f_.html" onMouseOver="F_roll('Navigationsschaltflaeche13',1)" onMouseOut="F_roll('Navigationsschaltflaeche13',0)"><IMG ID="Navigationsschaltflaeche13" NAME="Navigationsschaltflaeche13" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/Current_news_in_Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'Current_news_in_NRbutton_sec_3.jpg',0)" BORDER=0 ALT="Current news in" TITLE="Current news in"></A></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/prediction_of_f_.html" onMouseOver="F_roll('Navigationsschaltflaeche14',1)" onMouseOut="F_roll('Navigationsschaltflaeche14',0)"><IMG ID="Navigationsschaltflaeche14" NAME="Navigationsschaltflaeche14" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/bioavailability_research__Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'bioavailability_research__NRbutton_sec_3.jpg',0)" BORDER=0 ALT="bioavailability research:" TITLE="bioavailability research:"></A></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/prediction_of_f_.html" onMouseOver="F_roll('Navigationsschaltflaeche15',1)" onMouseOut="F_roll('Navigationsschaltflaeche15',0)"><IMG ID="Navigationsschaltflaeche15" NAME="Navigationsschaltflaeche15" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/About_animal_models__Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'About_animal_models__NRbutton_sec_3.jpg',0)" BORDER=0 ALT="About animal models," TITLE="About animal models,"></A></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/prediction_of_f_.html" onMouseOver="F_roll('Navigationsschaltflaeche16',1)" onMouseOut="F_roll('Navigationsschaltflaeche16',0)"><IMG ID="Navigationsschaltflaeche16" NAME="Navigationsschaltflaeche16" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/inter-subject_variability_Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'inter-subject_variability_NRbutton_sec_3.jpg',0)" BORDER=0 ALT="inter-subject variability" TITLE="inter-subject variability"></A></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/prediction_of_f_.html" onMouseOver="F_roll('Navigationsschaltflaeche17',1)" onMouseOut="F_roll('Navigationsschaltflaeche17',0)"><IMG ID="Navigationsschaltflaeche17" NAME="Navigationsschaltflaeche17" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/and_species_differences_Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'and_species_differences_NRbutton_sec_3.jpg',0)" BORDER=0 ALT="and species differences" TITLE="and species differences"></A></TD>
                        </TR>
                    </TABLE>
                </TD>
            </TR>
        </TABLE>
        <BR></P>
    <P STYLE="text-align: center; border: 1pt solid rgb(137,211,238); margin: 2pt;"><BR><BR>Bioavailability prediction of drug candidates for <BR>treatment of Type 2 diabetes <BR>(<A HREF="../html/partnerships.html">more</A>)<BR><BR><A HREF="../html/partnerships.html">...<I>and in short time our development project was taken to the next step.</I></A><I>&quot;<BR></I>&nbsp;</P>
    </LAYER></DIV><DIV ID="Text62LYR" CLASS="TextObject" STYLE="background-color: rgb(255,255,255); background-image: url('../assets/images/PixelHellblau.jpg');"><LAYER ID="Text62LYR" VISIBILITY=INHERIT TOP=1126 LEFT=0 WIDTH=184 HEIGHT=971 Z-INDEX=14  bgcolor="#FFFFFF" background="../assets/images/PixelHellblau.jpg">
    <P STYLE="text-align: center; border: 1pt solid rgb(137,211,238); margin: 2pt;"><BR>
        <TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0 NOF=TE>
            <TR>
                <TD ALIGN="CENTER"><IMG ID="Bild22" HEIGHT=113 WIDTH=170 SRC="../assets/images/IMPACT-F_343-6_170.png" BORDER=0 ALT="" USEMAP="#map2"><MAP NAME="map2"><AREA SHAPE=RECT ALT="" COORDS="0,0,170,113" HREF="../html/impact-f.html"></MAP></TD>
            </TR>
        </TABLE>
        <BR></P>
    <P STYLE="text-align: center; border: 1pt solid rgb(137,211,238); margin: 2pt;"><BR>
        <TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0 NOF=TE>
            <TR>
                <TD ALIGN="CENTER">
                    <TABLE ID="Navigationsleiste6" BORDER=0 BGCOLOR="#FFFFFF" CELLSPACING=4 CELLPADDING=0 NOF=NB_UNVSNY020NOF=NB_UNVSNY020NOF=NB_UNVSNY020 WIDTH=168>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/prediction_of_f_.html" onMouseOver="F_roll('Navigationsschaltflaeche21',1)" onMouseOut="F_roll('Navigationsschaltflaeche21',0)"><IMG ID="Navigationsschaltflaeche21" NAME="Navigationsschaltflaeche21" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/Validation_of_IMPACT-F_Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'Validation_of_IMPACT-F_NRbutton_sec_3.jpg',0)" BORDER=0 ALT="Validation of IMPACT-F" TITLE="Validation of IMPACT-F"></A></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><IMG ID="Navigationsschaltflaeche22" NAME="Navigationsschaltflaeche22" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/Brochure__pdf__Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'Brochure__pdf__NRbutton_sec_3.jpg',0)" BORDER=0 ALT="Brochure (pdf)" TITLE="Brochure (pdf)"></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="mailto:prediction-service@pharmaInformatic.com" onMouseOver="F_roll('Navigationsschaltflaeche23',1)" onMouseOut="F_roll('Navigationsschaltflaeche23',0)"><IMG ID="Navigationsschaltflaeche23" NAME="Navigationsschaltflaeche23" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/Prediction_Service__email__Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'Prediction_Service__email__NRbutton_sec_3.jpg',0)" BORDER=0 ALT="Prediction Service (email)" TITLE="Prediction Service (email)"></A></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/pact-f.html" onMouseOver="F_roll('Navigationsschaltflaeche24',1)" onMouseOut="F_roll('Navigationsschaltflaeche24',0)"><IMG ID="Navigationsschaltflaeche24" NAME="Navigationsschaltflaeche24" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/PACT-F__knowledge_base__Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'PACT-F__knowledge_base__NRbutton_sec_3.jpg',0)" BORDER=0 ALT="PACT-F (knowledge base)" TITLE="PACT-F (knowledge base)"></A></TD>
                        </TR>
                    </TABLE>
                </TD>
            </TR>
        </TABLE>
        <BR></P>
    <P STYLE="text-align: center; border: 1pt solid rgb(137,211,238); margin: 2pt;"><BR>
        <TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0 NOF=TE>
            <TR>
                <TD ALIGN="CENTER">
                    <TABLE ID="Navigationsleiste7" BORDER=0 BGCOLOR="#FFFFFF" CELLSPACING=0 CELLPADDING=0 NOF=NB_UNVSNY020NOF=NB_UNVSNY020NOF=NB_UNVSNY020 WIDTH=160>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/prediction_of_f_.html" onMouseOver="F_roll('Navigationsschaltflaeche25',1)" onMouseOut="F_roll('Navigationsschaltflaeche25',0)"><IMG ID="Navigationsschaltflaeche25" NAME="Navigationsschaltflaeche25" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/Current_news_in_Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'Current_news_in_NRbutton_sec_3.jpg',0)" BORDER=0 ALT="Current news in" TITLE="Current news in"></A></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/prediction_of_f_.html" onMouseOver="F_roll('Navigationsschaltflaeche26',1)" onMouseOut="F_roll('Navigationsschaltflaeche26',0)"><IMG ID="Navigationsschaltflaeche26" NAME="Navigationsschaltflaeche26" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/bioavailability_research__Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'bioavailability_research__NRbutton_sec_3.jpg',0)" BORDER=0 ALT="bioavailability research:" TITLE="bioavailability research:"></A></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/prediction_of_f_.html" onMouseOver="F_roll('Navigationsschaltflaeche27',1)" onMouseOut="F_roll('Navigationsschaltflaeche27',0)"><IMG ID="Navigationsschaltflaeche27" NAME="Navigationsschaltflaeche27" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/About_animal_models__Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'About_animal_models__NRbutton_sec_3.jpg',0)" BORDER=0 ALT="About animal models," TITLE="About animal models,"></A></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/prediction_of_f_.html" onMouseOver="F_roll('Navigationsschaltflaeche28',1)" onMouseOut="F_roll('Navigationsschaltflaeche28',0)"><IMG ID="Navigationsschaltflaeche28" NAME="Navigationsschaltflaeche28" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/inter-subject_variability_Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'inter-subject_variability_NRbutton_sec_3.jpg',0)" BORDER=0 ALT="inter-subject variability" TITLE="inter-subject variability"></A></TD>
                        </TR>
                        <TR VALIGN=TOP ALIGN=LEFT>
                            <TD WIDTH=160 HEIGHT=18><A HREF="../html/prediction_of_f_.html" onMouseOver="F_roll('Navigationsschaltflaeche29',1)" onMouseOut="F_roll('Navigationsschaltflaeche29',0)"><IMG ID="Navigationsschaltflaeche29" NAME="Navigationsschaltflaeche29" HEIGHT=18 WIDTH=160 SRC="../assets/images/autogen/and_species_differences_Nbutton_sec_1.jpg" onLoad="F_loadRollover(this,'and_species_differences_NRbutton_sec_3.jpg',0)" BORDER=0 ALT="and species differences" TITLE="and species differences"></A></TD>
                        </TR>
                    </TABLE>
                </TD>
            </TR>
        </TABLE>
        <BR></P>
    <P STYLE="text-align: center; margin: 2pt; border-left-style: none; border-top-style: none; border-right-style: none; border-bottom-style: none;"><BR>Recent News:<BR><BR>Selection and prioritisation of lead compounds for the treatment of inflammatory and autoimmune diseases based on estimated oral bioavailability in humans with IMPACT-F.<BR>(<A HREF="../html/partnerships.html">more</A>)<BR>&nbsp;</P>
    <P STYLE="text-align: center; margin: 2pt; border-left-style: none; border-top-style: none; border-right-style: none; border-bottom-style: none;">&nbsp;</P>
    <P STYLE="text-align: center; margin: 2pt; border-left-style: none; border-top-style: none; border-right-style: none; border-bottom-style: none;">&nbsp;</P>
    <P STYLE="text-align: center; margin: 2pt; border-left-style: none; border-top-style: none; border-right-style: none; border-bottom-style: none;">Novel models to forecast <BR><A HREF="../html/plasma_protein_binding.html"><B>Plasma Protein Binding</B></A><BR>of compounds<BR>show a high quality of prediction.<BR><BR>Based on a large <BR>independent validation dataset.<BR>a low error <BR>and high correlation <BR>between experimental and predicted PPB values was found.</P>
    </LAYER></DIV><DIV ID="Text64LYR" CLASS="TextObject" STYLE="background-color: rgb(255,255,255); background-image: url('../assets/images/PixelHellblau.jpg');"><LAYER ID="Text64LYR" VISIBILITY=INHERIT TOP=2379 LEFT=0 WIDTH=184 HEIGHT=354 Z-INDEX=15  bgcolor="#FFFFFF" background="../assets/images/PixelHellblau.jpg">
    <P STYLE="text-align: center; border: 1pt solid rgb(137,211,238); margin: 2pt;"><BR>
        <TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0 NOF=TE>
            <TR>
                <TD ALIGN="CENTER"><IMG ID="Bild25" HEIGHT=113 WIDTH=170 SRC="../assets/images/IMPACT-F_343-6_170.png" BORDER=0 ALT="" USEMAP="#map3"><MAP NAME="map3"><AREA SHAPE=RECT ALT="" COORDS="0,0,170,113" HREF="../html/impact-f.html"></MAP></TD>
            </TR>
        </TABLE>
        <BR></P>
    <P STYLE="text-align: center; border: 1pt solid rgb(137,211,238); margin: 2pt;"><BR>Selection and prioritisation <BR>of prodrugs <BR>for the treatment of <BR>cancer<BR>based on estimated oral bioavailability in humans <BR>with IMPACT-F.<BR>(<A HREF="../html/partnerships.html">more</A>)<BR>&nbsp;</P>
    </LAYER></DIV></LAYER></DIV>
    <SCRIPT language="javascript">
    F_menu(new Array('Navigationsleiste21', '../html/partnerships.html','../assets/images/autogen/Partnerships_Nbutton_sec_1.jpg','../assets/images/autogen/Partnerships_NRbutton_sec_3.jpg','../html/contact_us.html','../assets/images/autogen/Contact_us_Nbutton_sec_1.jpg','../assets/images/autogen/Contact_us_NRbutton_sec_3.jpg'));
    F_menu(new Array('Navigationsleiste22', '../html/impact-f.html','../assets/images/autogen/IMPACT-F_Nbutton_sec_1.jpg','../assets/images/autogen/IMPACT-F_NRbutton_sec_3.jpg','../html/molscore-drugs.html','../assets/images/autogen/MolScore-Drugs_Nbutton_sec_1.jpg','../assets/images/autogen/MolScore-Drugs_NRbutton_sec_3.jpg','../html/molscore-antibiotics.html','../assets/images/autogen/MolScore-Antibiotics_Nbutton_sec_1.jpg','../assets/images/autogen/MolScore-Antibiotics_NRbutton_sec_3.jpg','../html/molscore-antivirals.html','../assets/images/autogen/MolScore-Antivirals_Nbutton_sec_1.jpg','../assets/images/autogen/MolScore-Antivirals_NRbutton_sec_3.jpg','../html/adme___tox_predictions.html','../assets/images/autogen/ADME___Tox_predictions_Nbutton_sec_1.jpg','../assets/images/autogen/ADME___Tox_predictions_NRbutton_sec_3.jpg'));
    F_menu(new Array('Navigationsleiste23', '../html/plasma_protein_binding.html','../assets/images/autogen/Plasma_Protein_Binding_Nbutton_sec_1.jpg','../assets/images/autogen/Plasma_Protein_Binding_NRbutton_sec_3.jpg','../html/oral_bioavailability__f__.html','../assets/images/autogen/Oral_bioavailability__F___Nbutton_sec_1.jpg','../assets/images/autogen/Oral_bioavailability__F___NRbutton_sec_3.jpg','../html/pact-f.html','../assets/images/autogen/PACT-F_Nbutton_sec_1.jpg','../assets/images/autogen/PACT-F_NRbutton_sec_3.jpg','../html/content_of_pact-f.html','../assets/images/autogen/Content_of_PACT-F_Nbutton_sec_1.jpg','../assets/images/autogen/Content_of_PACT-F_NRbutton_sec_3.jpg','../html/use_of_pact-f.html','../assets/images/autogen/Use_of_PACT-F_Nbutton_sec_1.jpg','../assets/images/autogen/Use_of_PACT-F_NRbutton_sec_3.jpg','../html/what_influences_f__.html','../assets/images/autogen/What_influences_F___Nbutton_sec_1.jpg','../assets/images/autogen/What_influences_F___NRbutton_sec_3.jpg'));
    F_menu(new Array('Navigationsleiste24', '../html/lead_prioritisation.html','../assets/images/autogen/Lead_prioritisation_Nbutton_sec_1.jpg','../assets/images/autogen/Lead_prioritisation_NRbutton_sec_3.jpg'));
    F_menu(new Array('Navigationsleiste25', '../html/press_releases.html','../assets/images/autogen/Press_releases_Nbutton_sec_1.jpg','../assets/images/autogen/Press_releases_NRbutton_sec_3.jpg','../html/in_the_news.html','../assets/images/autogen/In_the_News_Nbutton_sec_1.jpg','../assets/images/autogen/In_the_News_NRbutton_sec_3.jpg','../html/downloads.html','../assets/images/autogen/Downloads_Nbutton_sec_1.jpg','../assets/images/autogen/Downloads_NRbutton_sec_3.jpg','../html/site_map.html','../assets/images/autogen/Site_map_Nbutton_sec_1.jpg','../assets/images/autogen/Site_map_NRbutton_sec_3.jpg'));
    </SCRIPT>
</BODY>
</HTML>
 